| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/07/1991 | CA1283829C Dosage form comprising solubility regulating member |
| 05/05/1991 | WO1991006282A1 Small particle drug compositions |
| 05/03/1991 | WO1991006322A1 Magnetocontrollable carrier with physiologically active substance and method for making said carrier |
| 05/03/1991 | WO1991006292A1 Process of preparing a water dispersible hydrophobic or aerophilic solid |
| 05/03/1991 | CA2045504A1 Magnetically controlled carrier with physiologically active agent and process for preparing thereof |
| 05/02/1991 | WO1991005771A1 Lipophilic acylpyrazinamide prodrugs |
| 05/02/1991 | WO1991005599A1 Process for making aqueous dispersions |
| 05/02/1991 | WO1991005548A1 Sustained release composition for macromolecular proteins |
| 05/02/1991 | WO1991005544A1 Drug delivery system, method for preparing the same, and use thereof |
| 05/02/1991 | WO1991005542A1 Ultraviolet radiation screening drops for the eyes |
| 05/02/1991 | WO1991005529A1 Drug delivery systems and matrix therefor |
| 05/02/1991 | WO1991003442A3 Process for separating mixtures of partially fluorinated or perfluorinated hydrocarbon compounds |
| 05/02/1991 | EP0425450A2 Maltodextrin/defoaming composition combinate |
| 05/02/1991 | EP0425443A1 Injectable antiparasitic agent |
| 05/02/1991 | EP0425373A1 Pharmaceutical and cosmetic composition containing cross-linked poly-beta-alamine spheres impregnated by lipophilic substances |
| 05/02/1991 | EP0425362A2 Furosemide salts, process for their preparation, their use as medicines and pharmaceutical compositions containing them |
| 05/02/1991 | EP0425298A2 Sustained-release preparation of basic medical agent hydrochloride |
| 05/02/1991 | EP0425213A2 Dry solid compositions containing lipid |
| 05/02/1991 | EP0425154A1 Sustained release elements |
| 05/02/1991 | EP0425023A2 Cellulosic coating |
| 05/02/1991 | EP0424706A1 Chewable or suckable pharmaceutical form, process for its preparation and its use |
| 05/02/1991 | EP0424535A1 Device for controlled dosing of active substances into an operative medium |
| 05/02/1991 | EP0424534A1 Pharmaceutical preparation for treatment of mastitis in animals and humans |
| 05/02/1991 | DE3938227C1 Oral antiinflammatory and analgetic pharmaceutical compsn. - comprises magnesium ibuprofen dissolved in mixt. of water, propane-1,2-diol and glycerol |
| 05/02/1991 | DE3936328A1 Pharmazeutische praeparate Pharmaceutical products |
| 05/02/1991 | DE3935906A1 Galactose for (par)enteral nutrition of intensive care patients - as a glucose substitute in nutrient solns. which is more effective than glucose |
| 05/02/1991 | DE3935736A1 Pressed article for sustained pharmaceutical release - contg. poly-lactic acid and polymer of D-3-hydroxybutyric acid, providing good flow properties and easy compression |
| 05/02/1991 | CA2029022A1 Sugar beet pectins and their use in comestibles |
| 05/01/1991 | WO1991006310A1 Liposomal compositions |
| 05/01/1991 | CN1050988A Process making medicine used for male |
| 05/01/1991 | CN1050987A Stable immunogen composition for oral administration |
| 05/01/1991 | CA2066698A1 Liposomal compositions |
| 05/01/1991 | CA2028934A1 Encapsulated sweetener-flavor delivery system and method of preparation |
| 05/01/1991 | CA2028604A1 Injectable formulation for lipophilic drugs |
| 05/01/1991 | CA2025189A1 Method for using (2-imidazolin-2-ylamino)quinoxalines to reduce or maintain intraocular pressure |
| 04/30/1991 | US5011855 Oil extracted from pips of Ribes genus fruits |
| 04/30/1991 | US5011852 Liquid oral pharmaceutical compositions of non-steroidal anti-inflammatory drugs |
| 04/30/1991 | US5011824 Rectal motilin preparation |
| 04/30/1991 | US5011797 Glass microspheres containing oxides of group 3 elements which form beta-emitting isotopes after neutron radiation |
| 04/30/1991 | US5011694 Exposing matrix of compressed mixture of powdered drug and polymer to vapor of lower alcohol |
| 04/30/1991 | US5011692 Polymer layers with and without drug disposed alternatingly and coated with insoluble polymer; for embedding beneath skin |
| 04/30/1991 | US5011691 Protein from DNA expression, a pair of polypeptide chains; implanting to induce endochondral bone formation in mammals |
| 04/30/1991 | US5011690 Mixing aqueous stabilized silica sol containing dispersed material and aqueous polymer solution to form two-phase system, condensing to aggregate silica drops into spheres containing included material |
| 04/30/1991 | US5011688 Liquid composition for the relief of premenstrual and menstrual discomforts |
| 04/30/1991 | US5011678 Suspension of biocompatible polypeptide drug, steroid and fluorocarbon propellant; for mucosal area; antidiabetic, osteoporosis, Paget*s disease; sodium tauro-24,25-dihydro-fusidate |
| 04/30/1991 | US5011677 For radiation therapy |
| 04/30/1991 | US5011532 Spun sugar fiber as aids for dispersing oils into water to form colloids |
| 04/30/1991 | US5010685 Encapsulated in mixture of ethylene-vinyl acetate copolymer and wax matrices |
| 04/30/1991 | CA1283655C Acid decrystallization of aminopolysaccharides and derivatives thereof |
| 04/30/1991 | CA1283607C Stable injectable pharmaceutical formulation for 1,4- dihydroxy-5-8-bis¬2-(2-hydroxyethylamino)-ethylamino| anthraquinone, dihydrochloride |
| 04/30/1991 | CA1283606C Phospholipid-containing products, their preparation and their use |
| 04/30/1991 | CA1283605C Pharmaceutical composition for suppository containing buprenorphine |
| 04/30/1991 | CA1283604C2 Dehydrated liposomes |
| 04/30/1991 | CA1283603C Translucent water-in-oil emulsions |
| 04/30/1991 | CA1283602C Pre-s gene coded peptide hepatitis b immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers |
| 04/29/1991 | CA2028665A1 Bioavailability of pharmaceutical active compounds with peptide linkages |
| 04/28/1991 | WO1991006285A1 Reconstitution method |
| 04/28/1991 | CA2069919A1 Reconstituted method |
| 04/28/1991 | CA2028633A1 Sustained-release preparation of basic medical agent hydrochloride |
| 04/28/1991 | CA2028536A1 Injectable parasiticidal composition |
| 04/25/1991 | DE3935257A1 Liposome(s) contg. fluorescent marker and coupled to antibody - useful as diagnostic reagent and for targetted delivery of therapeutic agent for treating cancer, malaria etc. |
| 04/25/1991 | CA2067821A1 Infective drug delivery system using recombinant retroviral vectors |
| 04/25/1991 | CA2028326A1 Furosemide salts, process for the preparation thereof, application as medicaments and pharmaceutical compositions containing them |
| 04/25/1991 | CA2028307A1 Cosmetic and pharmaceutic compositions containing reticulated poly-.beta-alanine spheres impregnated with a lipophilic substance |
| 04/24/1991 | EP0424168A1 Polymer complexes of a sugar response type |
| 04/24/1991 | EP0424059A1 Use of sustituted imidazoles for the manufacture of an analgesic |
| 04/24/1991 | EP0424043A1 Liquid aqueous ophthalmic composition undergoing liquid-gel phase transition |
| 04/24/1991 | EP0424042A1 Non-solid ophthalmic composition and process for preparing the said composition |
| 04/24/1991 | EP0423748A1 Stabilized pharmaceutical composition and its production |
| 04/24/1991 | EP0423701A2 Granulating and coating method and apparatus therefor |
| 04/24/1991 | EP0423697A2 Emulsion of lipid containing a prostaglandin analogue |
| 04/24/1991 | EP0423695A2 Aerosol composition for topical medicament |
| 04/24/1991 | EP0423484A1 Tablet with sustained release |
| 04/24/1991 | EP0423317A1 Invasive microorganisms |
| 04/24/1991 | EP0423289A1 Composition of beneficial agent and method for administering the same by controlled dissolution. |
| 04/24/1991 | EP0423129A1 Heterocyclic containing cellulosic graft polymers |
| 04/24/1991 | CA2028256A1 Multiple layer transdermal drug administration system |
| 04/24/1991 | CA2028213A1 Dry solid compositions containing lipid |
| 04/24/1991 | CA2027865A1 Sustained release elements |
| 04/23/1991 | US5010073 Use of liposomes as carriers for metalloporphyrins |
| 04/23/1991 | US5010069 Stable liquid form of 5-aminosalicylic acid |
| 04/23/1991 | US5010067 Triglyceride-water emulsion pharmaceutical vehicles |
| 04/23/1991 | US5010056 Pharmaceutical composition for intranasal administration, comprising GH-releasing hormone, a cholinergic agonist and optionally a bile salt |
| 04/23/1991 | US5009897 Pharmaceutical granules and tablets made therefrom |
| 04/23/1991 | US5009896 Readily divisible into sub-dosage units of two or three parts |
| 04/23/1991 | US5009895 Sustained release with high and low viscosity HPMC |
| 04/23/1991 | US5009894 Arrangement for and method of administering a pharmaceutical preparation |
| 04/23/1991 | US5009892 Rapid miosis with control of intraocular pressure |
| 04/23/1991 | US5009890 Burn treatment product |
| 04/23/1991 | US5009819 Taste moderating composition |
| 04/23/1991 | CA1283497C Polymer-treated ion exchange resins |
| 04/23/1991 | CA1283405C Crystalline hydrate of oral cephalosporin and its composition |
| 04/23/1991 | CA1283391C Method of sealing hard gelatin capsules |
| 04/23/1991 | CA1283360C Process for the preparation of a viscosity-stable antacid composition |
| 04/23/1991 | CA1283359C Compositions of neocarzinostatin derivative for non-injection administration |
| 04/23/1991 | CA1283358C Insulin preparation |
| 04/23/1991 | CA1283355C Method for delivering an active ingredient by controlled time release utilizing a novel delivery vehicle which can be prepared by a process utilizing the active ingredient as a porogen |
| 04/21/1991 | WO1991005546A1 Solid tumor treatment method and composition |
| 04/21/1991 | WO1991005545A1 Liposome microreservoir composition and method |
| 04/20/1991 | WO1991005736A1 Hydrophilic polymer-silicate mineral composite and its use |